Rentschler Biopharma SE has appointed Alexander Dettmer as Chief Financial Officer, effective July 1, 2020. He will be heading the finance, supply chain management, information technology and legal functions. Mr. Dettmer succeeds Stefan Rampf, who will be leaving the company, effective June 30, 2020 to pursue a new opportunity. Mr. Dettmer brings 15 years of financial, business development and leadership experience with a focus on driving operational excellence in the healthcare and life science...